The carbon footprint of transperineal prostate biopsy

Fuente: Wiley Open Access
Saved in:
Bibliographic Details
Main Authors: Daniel A. Carson, Ali Hooshyari, Jesse Gale, Greg Evans, Flavio V. Ordones, Lodewikus P. Vermeulen
Format: Artículo Open Access
Published: Wiley 2025
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867003611900280832
author Daniel A. Carson
Ali Hooshyari
Jesse Gale
Greg Evans
Flavio V. Ordones
Lodewikus P. Vermeulen
author_facet Daniel A. Carson
Ali Hooshyari
Jesse Gale
Greg Evans
Flavio V. Ordones
Lodewikus P. Vermeulen
Daniel A. Carson
Ali Hooshyari
Jesse Gale
Greg Evans
Flavio V. Ordones
Lodewikus P. Vermeulen
collection Wiley Open Access
contents The carbon footprint of transperineal prostate biopsy Daniel A. Carson Ali Hooshyari Jesse Gale Greg Evans Flavio V. Ordones Lodewikus P. Vermeulen BJUI Compass AbstractObjectiveTo evaluate the carbon footprint of transperineal prostate biopsy (TPPB). Climate change is the biggest global public health threat of the 21st century. Healthcare contributes 5% to global greenhouse gas emissions. Despite growing enthusiasm for sustainable urology, there is little data on the environmental impact of urological practice.Patients and methodsEmissions associated with TPPB (under local anaesthesia) at a hospital in Aotearoa New Zealand were estimated from electricity consumption, procurement of equipment/supplies, travel of staff and patients, waste disposal and sterilisation of linen. Emissions coefficients were used to determine CO2 equivalents (kgCO2e) emitted.ResultsTPPB was associated with 70 kgCO2e of emissions per case. This equates to 280 km of travel by car, or an economy seat on a 70‐minute flight. The largest contributors were procurement (76%) and travel (23%). Electricity, waste disposal and sterilisation of linen did not contribute significantly to emissions (cumulatively <1.5%).ConclusionsThis is the first study to evaluate the carbon footprint of a TPPB. Emissions were derived mostly from procurement and travel. These may be mitigated by review of standardised equipment packs, transitioning to reusables and introducing outreach biopsy clinics. Adherence to pragmatic evidence‐based guidelines for prostate cancer may reduce emissions associated with overdiagnosis and unnecessary biopsies. Further research is required to characterise the broader environmental impact of urology services. 10.1002/bco2.70063 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1002/bco2.70063
format Artículo Open Access
id wiley_oa_10_1002_bco2_70063
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle The carbon footprint of transperineal prostate biopsy
Daniel A. Carson
Ali Hooshyari
Jesse Gale
Greg Evans
Flavio V. Ordones
Lodewikus P. Vermeulen
BJUI Compass
The carbon footprint of transperineal prostate biopsy Daniel A. Carson Ali Hooshyari Jesse Gale Greg Evans Flavio V. Ordones Lodewikus P. Vermeulen BJUI Compass AbstractObjectiveTo evaluate the carbon footprint of transperineal prostate biopsy (TPPB). Climate change is the biggest global public health threat of the 21st century. Healthcare contributes 5% to global greenhouse gas emissions. Despite growing enthusiasm for sustainable urology, there is little data on the environmental impact of urological practice.Patients and methodsEmissions associated with TPPB (under local anaesthesia) at a hospital in Aotearoa New Zealand were estimated from electricity consumption, procurement of equipment/supplies, travel of staff and patients, waste disposal and sterilisation of linen. Emissions coefficients were used to determine CO2 equivalents (kgCO2e) emitted.ResultsTPPB was associated with 70 kgCO2e of emissions per case. This equates to 280 km of travel by car, or an economy seat on a 70‐minute flight. The largest contributors were procurement (76%) and travel (23%). Electricity, waste disposal and sterilisation of linen did not contribute significantly to emissions (cumulatively <1.5%).ConclusionsThis is the first study to evaluate the carbon footprint of a TPPB. Emissions were derived mostly from procurement and travel. These may be mitigated by review of standardised equipment packs, transitioning to reusables and introducing outreach biopsy clinics. Adherence to pragmatic evidence‐based guidelines for prostate cancer may reduce emissions associated with overdiagnosis and unnecessary biopsies. Further research is required to characterise the broader environmental impact of urology services. 10.1002/bco2.70063 http://creativecommons.org/licenses/by/4.0/
title The carbon footprint of transperineal prostate biopsy
topic BJUI Compass
url https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.70063